Insights

Here’s why the Imugene (ASX:IMU) share price opened 8% higher today

The Imugene Limited (ASX: IMU) share price is on the move today after news from the company on its HER-Vaxx’s clinical trial.
The post Here’s why the Imugene (ASX:IMU) share price opened 8% higher today appeared first on The Motley Fool Australia. –

increase in asx medical software share price represented by doctor making excited hands up gesture

Imugene Limited (ASX: IMU) shares are on the rise today after news from the company on its HER-Vaxx’s clinical trial. The Imugene share price opened today’s session 8.15% higher at 20 cents before climbing to an intraday high of 21.5 cents. At the time of writing, the company’s shares have retreated back to 19 cents, up 2.7%.

Let’s take a closer look at today’s news from Imugene.

What’s boosting the Imugene share price? 

The Imugene share price is responding positively after the biotech announced today that the second clinical endpoint for its HER-Vaxx clinical studies has been met.

HER-Vaxx is an immunotherapy to treat tumours that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers.

The first clinical end point was overall patient survival, while the second was progression-free survival (PFS).

The company states its second clinical endpoint has been met, as a statistically significant amount of PFS has occurred.

The trial is the second phase of HER-Vaxx trials. It’s being conducted in multiple sites across Eastern Europe and India, where clinicians have difficulty accessing antibody treatments and there are high levels of gastric cancer.

Data from 24 PFS events will now be analysed. The company stated final PFS results are expected in the coming months.

Commentary from management

Imugene managing director and CEO Leslie Chong commented on the company’s news. She said:

I am delighted to report that we have achieved this new significant milestone for patients with advanced gastric cancer, following on from the important interim data released in 2020 and new data presented at AACR earlier this month. I look forward to updating the market as the data is analysed.

Imugene share price snapshot

Imugene shares have been having a roaring time on the ASX lately.

Currently, the Imugene share price is up by 90% year to date. It’s also up by 850% over the last 12 months.

The company has a market capitalisation of around $881 million, with approximately 4.7 million shares outstanding.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Here’s why the Imugene (ASX:IMU) share price opened 8% higher today appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!